NVS logo

Novartis AG (NVS) Cash from investing

annual CFI:

-$7.51B-$13.11B(-234.26%)
December 31, 2024

Summary

  • As of today (May 21, 2025), NVS annual cash flow from investing activities is -$7.51 billion, with the most recent change of -$13.11 billion (-234.26%) on December 31, 2024.
  • During the last 3 years, NVS annual CFI has fallen by -$11.72 billion (-278.54%).
  • NVS annual CFI is now -234.26% below its all-time high of $5.60 billion, reached on December 31, 2023.

Performance

NVS Cash from investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVScash flow metrics

quarterly CFI:

$330.00M+$3.36B(+110.88%)
March 31, 2025

Summary

  • As of today (May 21, 2025), NVS quarterly cash flow from investing activities is $330.00 million, with the most recent change of +$3.36 billion (+110.88%) on March 31, 2025.
  • Over the past year, NVS quarterly CFI has increased by +$1.23 billion (+136.71%).
  • NVS quarterly CFI is now -96.89% below its all-time high of $10.62 billion, reached on March 31, 2023.

Performance

NVS quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVScash flow metrics

TTM CFI:

-$6.28B+$1.23B(+16.36%)
March 31, 2025

Summary

  • As of today (May 21, 2025), NVS TTM cash flow from investing activities is -$6.28 billion, with the most recent change of +$1.23 billion (+16.36%) on March 31, 2025.
  • Over the past year, NVS TTM CFI has dropped by -$360.00 million (-6.08%).
  • NVS TTM CFI is now -147.25% below its all-time high of $13.30 billion, reached on June 30, 2023.

Performance

NVS TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVScash flow metrics

Cash from investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

NVS Cash from investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-234.3%+136.7%-6.1%
3 y3 years-278.5%-96.5%-149.1%
5 y5 years-237.5%+103.3%+54.1%

NVS Cash from investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-234.3%at low-96.9%+102.8%-147.3%+22.2%
5 y5-year-234.3%+43.0%-96.9%+102.8%-147.3%+54.1%
alltimeall time-234.3%+52.3%-96.9%+102.5%-147.3%+69.2%

NVS Cash from investing History

DateAnnualQuarterlyTTM
Mar 2025
-
$330.00M(-110.9%)
-$6.28B(-16.4%)
Dec 2024
-$7.51B(-234.3%)
-$3.03B(+711.0%)
-$7.51B(+20.4%)
Sep 2024
-
-$374.00M(-88.3%)
-$6.24B(-22.8%)
Jun 2024
-
-$3.21B(+256.7%)
-$8.08B(+36.4%)
Mar 2024
-
-$899.00M(-48.9%)
-$5.92B(-205.9%)
Dec 2023
$5.60B(+281.2%)
-$1.76B(-20.4%)
$5.60B(-5.0%)
Sep 2023
-
-$2.21B(+110.1%)
$5.89B(-55.7%)
Jun 2023
-
-$1.05B(-109.9%)
$13.30B(+388.2%)
Mar 2023
-
$10.62B(-824.0%)
$2.72B(+85.6%)
Dec 2022
$1.47B(-65.1%)
-$1.47B(-128.2%)
$1.47B(-80.4%)
Sep 2022
-
$5.20B(-144.7%)
$7.50B(+602.1%)
Jun 2022
-
-$11.63B(-224.2%)
$1.07B(-91.7%)
Mar 2022
-
$9.37B(+105.2%)
$12.79B(+204.0%)
Dec 2021
$4.21B(-131.9%)
$4.56B(-470.4%)
$4.21B(-554.4%)
Sep 2021
-
-$1.23B(-1370.1%)
-$926.00M(-46.8%)
Jun 2021
-
$97.00M(-87.6%)
-$1.74B(-23.1%)
Mar 2021
-
$780.00M(-236.6%)
-$2.26B(-82.8%)
Dec 2020
-$13.18B(+492.2%)
-$571.00M(-72.1%)
-$13.18B(+7.2%)
Sep 2020
-
-$2.04B(+381.2%)
-$12.29B(-9.9%)
Jun 2020
-
-$425.00M(-95.8%)
-$13.65B(-0.4%)
Mar 2020
-
-$10.14B(-3289.0%)
-$13.70B(+515.2%)
Dec 2019
-$2.23B(-60.2%)
$318.00M(-109.4%)
-$2.23B(-70.2%)
Sep 2019
-
-$3.40B(+616.9%)
-$7.48B(+50.6%)
Jun 2019
-
-$474.00M(-135.7%)
-$4.97B(+2856.5%)
Mar 2019
-
$1.33B(-126.9%)
-$168.00M(-97.0%)
Dec 2018
-$5.59B(+79.3%)
-$4.93B(+457.0%)
-$5.59B(+238.4%)
Sep 2018
-
-$886.00M(-120.5%)
-$1.65B(+13.9%)
Jun 2018
-
$4.33B(-205.6%)
-$1.45B(-76.3%)
Mar 2018
-
-$4.09B(+311.1%)
-$6.11B(+96.0%)
Dec 2017
-$3.12B(-9.4%)
-$996.00M(+45.4%)
-$3.12B(-2.4%)
Sep 2017
-
-$685.00M(+103.3%)
-$3.20B(-2.1%)
Jun 2017
-
-$337.00M(-69.4%)
-$3.26B(-13.4%)
Mar 2017
-
-$1.10B(+2.6%)
-$3.77B(+9.6%)
Dec 2016
-$3.44B(-68.1%)
-$1.07B(+42.7%)
-$3.44B(-15.2%)
Sep 2016
-
-$752.00M(-10.9%)
-$4.06B(-0.0%)
Jun 2016
-
-$844.00M(+9.3%)
-$4.06B(-18.8%)
Mar 2016
-
-$772.00M(-54.3%)
-$5.00B(-53.6%)
Dec 2015
-$10.78B(-1324.1%)
-$1.69B(+124.4%)
-$10.78B(+7.7%)
Sep 2015
-
-$753.00M(-57.8%)
-$10.01B(+8.8%)
Jun 2015
-
-$1.78B(-72.8%)
-$9.21B(+8.3%)
Mar 2015
-
-$6.56B(+613.5%)
-$8.50B(-1064.7%)
Dec 2014
$881.00M(-126.3%)
-$919.00M(-1801.9%)
$881.00M(-203.0%)
Sep 2014
-
$54.00M(-105.0%)
-$855.00M(-48.6%)
Jun 2014
-
-$1.08B(-138.2%)
-$1.66B(+35.7%)
Mar 2014
-
$2.82B(-206.3%)
-$1.23B(-63.5%)
Dec 2013
-$3.35B
-$2.65B(+252.6%)
-$3.35B(+3.7%)
Sep 2013
-
-$753.00M(+17.7%)
-$3.23B(-27.4%)
DateAnnualQuarterlyTTM
Jun 2013
-
-$640.00M(-192.0%)
-$4.45B(-1.8%)
Mar 2013
-
$696.00M(-127.4%)
-$4.53B(-20.1%)
Dec 2012
-$5.67B(+616.5%)
-$2.54B(+28.7%)
-$5.67B(+43.2%)
Sep 2012
-
-$1.97B(+172.6%)
-$3.96B(+54.7%)
Jun 2012
-
-$723.00M(+62.5%)
-$2.56B(+48.2%)
Mar 2012
-
-$445.00M(-46.0%)
-$1.73B(+118.2%)
Dec 2011
-$792.00M(-95.0%)
-$824.00M(+44.8%)
-$792.00M(+42.7%)
Sep 2011
-
-$569.00M(-617.3%)
-$555.00M(-94.8%)
Jun 2011
-
$110.00M(-77.6%)
-$10.65B(-24.6%)
Mar 2011
-
$491.00M(-183.6%)
-$14.13B(-10.3%)
Dec 2010
-$15.76B(+10.8%)
-$587.00M(-94.5%)
-$15.76B(-18.6%)
Sep 2010
-
-$10.66B(+216.3%)
-$19.36B(+47.2%)
Jun 2010
-
-$3.37B(+196.7%)
-$13.15B(+5.1%)
Mar 2010
-
-$1.14B(-72.9%)
-$12.51B(-12.0%)
Dec 2009
-$14.22B(+37.2%)
-$4.19B(-5.8%)
-$14.22B(+21.0%)
Sep 2009
-
-$4.45B(+63.0%)
-$11.76B(-42.5%)
Jun 2009
-
-$2.73B(-3.9%)
-$20.43B(+22.7%)
Mar 2009
-
-$2.84B(+64.4%)
-$16.64B(+60.5%)
Dec 2008
-$10.37B(+66.0%)
-$1.73B(-86.8%)
-$10.37B(+0.5%)
Sep 2008
-
-$13.12B(-1348.6%)
-$10.32B(-4877.3%)
Jun 2008
-
$1.05B(-69.4%)
$216.00M(-113.1%)
Mar 2008
-
$3.43B(-304.3%)
-$1.64B(-73.7%)
Dec 2007
-$6.24B(-1.8%)
-$1.68B(-35.0%)
-$6.24B(+21.1%)
Sep 2007
-
-$2.59B(+220.3%)
-$5.16B(+72.9%)
Jun 2007
-
-$808.00M(-30.8%)
-$2.98B(-57.8%)
Mar 2007
-
-$1.17B(+96.5%)
-$7.08B(+11.3%)
Dec 2006
-$6.36B(-11.3%)
-$594.00M(+43.5%)
-$6.36B(-5.9%)
Sep 2006
-
-$414.00M(-91.6%)
-$6.75B(-30.2%)
Jun 2006
-
-$4.90B(+994.0%)
-$9.67B(-3.5%)
Mar 2006
-
-$448.00M(-54.8%)
-$10.02B(+39.8%)
Dec 2005
-$7.17B(+154.5%)
-$991.00M(-70.3%)
-$7.17B(+29.7%)
Sep 2005
-
-$3.33B(-36.5%)
-$5.53B(+47.3%)
Jun 2005
-
-$5.25B(-318.4%)
-$3.75B(-528.3%)
Mar 2005
-
$2.40B(+269.7%)
$876.00M(-131.1%)
Dec 2004
-$2.82B(+128.8%)
$650.00M(-141.7%)
-$2.82B(-24.6%)
Sep 2004
-
-$1.56B(+151.1%)
-$3.73B(+20.4%)
Jun 2004
-
-$620.00M(-51.9%)
-$3.10B(+25.7%)
Mar 2004
-
-$1.29B(+381.0%)
-$2.47B(+100.5%)
Dec 2003
-$1.23B(-57.0%)
-$268.00M(-71.0%)
-$1.23B(+27.8%)
Sep 2003
-
-$925.00M(-6707.1%)
-$963.00M(+2434.2%)
Jun 2003
-
$14.00M(-126.9%)
-$38.00M(-26.9%)
Mar 2003
-
-$52.00M
-$52.00M
Dec 2002
-$2.87B(+3.4%)
-
-
Dec 2001
-$2.77B(+1968.7%)
-
-
Dec 2000
-$134.00M(-92.9%)
-
-
Dec 1999
-$1.89B(-32.1%)
-
-
Dec 1998
-$2.79B
-
-

FAQ

  • What is Novartis AG annual cash flow from investing activities?
  • What is the all time high annual CFI for Novartis AG?
  • What is Novartis AG annual CFI year-on-year change?
  • What is Novartis AG quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Novartis AG?
  • What is Novartis AG quarterly CFI year-on-year change?
  • What is Novartis AG TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Novartis AG?
  • What is Novartis AG TTM CFI year-on-year change?

What is Novartis AG annual cash flow from investing activities?

The current annual CFI of NVS is -$7.51B

What is the all time high annual CFI for Novartis AG?

Novartis AG all-time high annual cash flow from investing activities is $5.60B

What is Novartis AG annual CFI year-on-year change?

Over the past year, NVS annual cash flow from investing activities has changed by -$13.11B (-234.26%)

What is Novartis AG quarterly cash flow from investing activities?

The current quarterly CFI of NVS is $330.00M

What is the all time high quarterly CFI for Novartis AG?

Novartis AG all-time high quarterly cash flow from investing activities is $10.62B

What is Novartis AG quarterly CFI year-on-year change?

Over the past year, NVS quarterly cash flow from investing activities has changed by +$1.23B (+136.71%)

What is Novartis AG TTM cash flow from investing activities?

The current TTM CFI of NVS is -$6.28B

What is the all time high TTM CFI for Novartis AG?

Novartis AG all-time high TTM cash flow from investing activities is $13.30B

What is Novartis AG TTM CFI year-on-year change?

Over the past year, NVS TTM cash flow from investing activities has changed by -$360.00M (-6.08%)
On this page